Logo der Universität Basel

Research Database / FORSCHUNGSDATENBANK 
 
 

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 

Publications

Showing records 1 - 20 (of 36)

Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID Author Year Title Publisher
4407712  Zaman, K.; Winterhalder, R.; Mamot, C.; Hasler-Strub, U.; Rochlitz, C.; Mueller, A.; Berset, C.; Wiliders, H.; Perey, L.; Rudolf, C. B.; Hawle, H.; Rondeau, S.; Neven, P. 2015 Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08 European Journal of Cancer
1192817  Zaman, K. 2011 Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06) Annals of oncology
3135340  Wicki, Andreas; Wild, Damian; Prêtre, Vincent; Mansi, Rosalba; Orleth, Annette; Reubi, Jean-Claude; Rochlitz, Christoph; Mamot, Christoph; Mäcke, Helmut R; Christofori, Gerhard 2014 Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors EJNMMI research
1193117  Wicki, Andreas; Rochlitz, Christoph; Orleth, Annette; Ritschard, Reto; Albrecht, Imke; Herrmann, Richard; Christofori, Gerhard; Mamot, Christoph 2012 Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth Clinical cancer research
2832808  Wicki, Andreas; Rochlitz, Christoph 2012 Targeted therapies in breast cancer Swiss medical weekly
4407714  Wicki, Andreas; Hermann, Frank; Prêtre, Vincent; Winterhalder, Ralph; Kueng, Marc; von Moos, Roger; Rochlitz, Christoph; Herrmann, Richard 2014 Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study Oncol Res Treat
4407713  Wicki, A.; Ritschard, R.; Loesch, U.; Deuster, S.; Rochlitz, C.; Mamot, C. 2015 Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial International Journal of Pharmaceutics
1194501  Vetter, Marcus; Tzankov, Alexandar; Engert, Andreas; Mehling, Matthias; Herrmann, Richard; Rochlitz, Christoph 2011 Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System : A Case Report and Review of the Literature Case Reports in Oncology
4407715  Templeton, Arnoud J.; Ribi, Karin; Surber, Christian; Sun, Hong; Hsu Schmitz, Shu-Fang; Beyeler, Michael; Dietrich, Daniel; Borner, Markus; Winkler, Annette; Müller, Andreas; von Rohr, Lukas; Winterhalder, Ralph C.; Rochlitz, Christoph; von Moos, Roger; Zaman, Khalil; Thürlimann, Beat J. K.; Ruhstaller, Thomas; Swiss Group for Clinical Cancer Research Coordinating Center, 2014 Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08) Breast
1192856  Schmid, S M; Myrick, M E; Forrer, F; Obermann, E C; Viehl, C T; Rochlitz, C; Güth, U 2011 Sentinel lymph node biopsy in primary breast cancer : trust the radiolabeled colloid method and avoid unnecessary procedures European journal of surgical oncology
1195880  Salzberg, M.; Kirson, E.; Palti, Y.; Rochlitz, C. 2008 A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors Onkologie
2383748  Romer, A.; Seiler, D.; Marincek, N.; Brunner, P.; Koller, M. T.; Ng, Q. K. T.; Maecke, H. R.; Mueller-Brand, J.; Rochlitz, C.; Briel, M.; Schindler, C.; Walter, M. A. 2014 Somatostatin-based radiopeptide therapy with [(177)Lu-DOTA]-TOC versus [ (90)Y-DOTA]-TOC in neuroendocrine tumours European journal of nuclear medicine and molecular imaging
1193484  Rochlitz, Christoph 2009 Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer Neoplasia
2832805  Rajski, Michal; Zanetti-Dällenbach, Rosanna; Vogel, Brigitte; Herrmann, Richard; Rochlitz, Christoph; Buess, Martin 2010 IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients BMC medicine
2832804  Rajski, M.; Vogel, B.; Baty, F.; Rochlitz, C.; Buess, M. 2012 Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer PLoS ONE
4407708  Pagani, Olivia; Klingbiel, Dirk; Ruhstaller, Thomas; Nole, Franco; Eppenberger-Castori, Serenella; Oehlschlegel, Christian; Bernhard, Jürg; Brauchli, Peter; Hess, Dagmar; Mamot, Christoph; Munzone, Elisabetta; Pestalozzi, Bernhard C.; Rabaglio, Manuela; Aebi, Stefan; Ribi, Karin; Rochlitz, Christoph; Rothgiesser, Karin; Thürlimann, Beat; von Moos, Roger; Zaman, Khalil; Goldhirsch, Aron; Swiss Group for Clinical Cancer, Research 2017 Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99 Annals of Oncology
3886346  Orleth, Annette; Mamot, Christoph; Rochlitz, Christoph; Ritschard, Reto; Alitalo, Kari; Christofori, Gerhard; Wicki, Andreas 2016 Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy Journal of Drug Targeting
4373873  Meier-Abt, F.; Bentires-Alj, M.; Rochlitz, C. 2015 Breast Cancer Prevention: Lessons to be Learned from Mechanisms of Early Pregnancy–Mediated Breast Cancer Protection Cancer Research
1635005  Marincek, Nicolas; Jörg, Ann-Catherine; Brunner, Philippe; Schindler, Christian; Koller, Michael T; Rochlitz, Christoph; Müller-Brand, Jan; Maecke, Helmut R; Briel, Matthias; Walter, Martin A 2013 Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study Journal of translational medicine
2832802  Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Stehle, Gregor; Dieterle, Thomas; Bubendorf, Lukas; Hilker, Christoph; Deuster, Stefanie; Herrmann, Richard; Rochlitz, Christoph 2012 Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study The Lancet oncology
Showing records 1 - 20 (of 36)


MCSS v5.8 PRO. 0.051 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
08/05/2024